InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Thistle Mary, Director. Officer active across 2 companies, notably Ziopharm Oncology INC. Cumulatively, 4 reports have been recorded. The latest transaction was disclosed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
040,000 shares0
Common Stock
SEC:0000899243-22-023997:0·
040,000 shares0
Common Stock
SEC:0000899243-22-024011:0·
05,000 shares0
Common Stock
SEC:0001209191-21-030743·
05,000 shares0
Common Stock
SEC:0001209191-21-030743:0·
4 of 4 declarations
About Thistle Mary
Mary Thistle is a Director at ZIOPHARM Oncology Inc and Alaunos Therapeutics, Inc. In this role, she provides expertise in strategy and corporate governance. Thistle plays a key role in performance assessment and strategic decision-making within the boards. Her experience in the biotechnology sector is an asset to the companies she serves.
